In their seminal study, Hoozemans et al. [62] demonstrated that the immunohistochemical staining of phosphorylated pPERK (activated) and UPR chaperone BiP/GRP78 were markedly increased in the neurons of temporal cortex and hippocampus in AD patients. Here, HSPA5 is linked to Alzheimer disease.